img

Global Drugs for HIV Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Drugs for HIV Market Insights, Forecast to 2034

HIV/AIDS is one of the most serious chronic diseases and the high prevalence of the disease in almost all parts of the world has resulted in an unprecedented awareness regarding the disease.
Market Analysis and InsightsGlobal Drugs for HIV Market
Global Drugs for HIV market is expected to reach to US$ 32440 million in 2024, with a positive growth of %, compared with US$ 30600 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Drugs for HIV industry is evaluated to reach US$ 45750 million in 2029. The CAGR will be 5.9% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Drugs for HIV market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Drugs for HIV market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


ViiV Healthcare
Gilead Sciences, Inc
Merck Sharp & Dohme Corp
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Theratechnologies Inc.
Viatris Pharmaceuticals Inc.
Genentech, Inc.
AbbVie Inc.
Segment by Type
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Integrase Inhibitors
Combination HIV Medicines
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drugs for HIV introduction, etc. Drugs for HIV Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Drugs for HIV
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for HIV Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.3 Integrase Inhibitors
1.2.4 Combination HIV Medicines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drugs for HIV Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for HIV Market Perspective (2018-2029)
2.2 Global Drugs for HIV Growth Trends by Region
2.2.1 Drugs for HIV Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs for HIV Historic Market Size by Region (2018-2024)
2.2.3 Drugs for HIV Forecasted Market Size by Region (2024-2029)
2.3 Drugs for HIV Market Dynamics
2.3.1 Drugs for HIV Industry Trends
2.3.2 Drugs for HIV Market Drivers
2.3.3 Drugs for HIV Market Challenges
2.3.4 Drugs for HIV Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drugs for HIV by Players
3.1.1 Global Drugs for HIV Revenue by Players (2018-2024)
3.1.2 Global Drugs for HIV Revenue Market Share by Players (2018-2024)
3.2 Global Drugs for HIV Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drugs for HIV, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Drugs for HIV Market Concentration Ratio
3.4.1 Global Drugs for HIV Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for HIV Revenue in 2022
3.5 Global Key Players of Drugs for HIV Head office and Area Served
3.6 Global Key Players of Drugs for HIV, Product and Application
3.7 Global Key Players of Drugs for HIV, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for HIV Breakdown Data by Type
4.1 Global Drugs for HIV Historic Market Size by Type (2018-2024)
4.2 Global Drugs for HIV Forecasted Market Size by Type (2024-2029)
5 Drugs for HIV Breakdown Data by Application
5.1 Global Drugs for HIV Historic Market Size by Application (2018-2024)
5.2 Global Drugs for HIV Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs for HIV Market Size (2018-2029)
6.2 North America Drugs for HIV Market Size by Type
6.2.1 North America Drugs for HIV Market Size by Type (2018-2024)
6.2.2 North America Drugs for HIV Market Size by Type (2024-2029)
6.2.3 North America Drugs for HIV Market Share by Type (2018-2029)
6.3 North America Drugs for HIV Market Size by Application
6.3.1 North America Drugs for HIV Market Size by Application (2018-2024)
6.3.2 North America Drugs for HIV Market Size by Application (2024-2029)
6.3.3 North America Drugs for HIV Market Share by Application (2018-2029)
6.4 North America Drugs for HIV Market Size by Country
6.4.1 North America Drugs for HIV Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drugs for HIV Market Size by Country (2018-2024)
6.4.3 North America Drugs for HIV Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drugs for HIV Market Size (2018-2029)
7.2 Europe Drugs for HIV Market Size by Type
7.2.1 Europe Drugs for HIV Market Size by Type (2018-2024)
7.2.2 Europe Drugs for HIV Market Size by Type (2024-2029)
7.2.3 Europe Drugs for HIV Market Share by Type (2018-2029)
7.3 Europe Drugs for HIV Market Size by Application
7.3.1 Europe Drugs for HIV Market Size by Application (2018-2024)
7.3.2 Europe Drugs for HIV Market Size by Application (2024-2029)
7.3.3 Europe Drugs for HIV Market Share by Application (2018-2029)
7.4 Europe Drugs for HIV Market Size by Country
7.4.1 Europe Drugs for HIV Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drugs for HIV Market Size by Country (2018-2024)
7.4.3 Europe Drugs for HIV Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drugs for HIV Market Size (2018-2029)
8.2 China Drugs for HIV Market Size by Type
8.2.1 China Drugs for HIV Market Size by Type (2018-2024)
8.2.2 China Drugs for HIV Market Size by Type (2024-2029)
8.2.3 China Drugs for HIV Market Share by Type (2018-2029)
8.3 China Drugs for HIV Market Size by Application
8.3.1 China Drugs for HIV Market Size by Application (2018-2024)
8.3.2 China Drugs for HIV Market Size by Application (2024-2029)
8.3.3 China Drugs for HIV Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drugs for HIV Market Size (2018-2029)
9.2 Asia Drugs for HIV Market Size by Type
9.2.1 Asia Drugs for HIV Market Size by Type (2018-2024)
9.2.2 Asia Drugs for HIV Market Size by Type (2024-2029)
9.2.3 Asia Drugs for HIV Market Share by Type (2018-2029)
9.3 Asia Drugs for HIV Market Size by Application
9.3.1 Asia Drugs for HIV Market Size by Application (2018-2024)
9.3.2 Asia Drugs for HIV Market Size by Application (2024-2029)
9.3.3 Asia Drugs for HIV Market Share by Application (2018-2029)
9.4 Asia Drugs for HIV Market Size by Region
9.4.1 Asia Drugs for HIV Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drugs for HIV Market Size by Region (2018-2024)
9.4.3 Asia Drugs for HIV Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drugs for HIV Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drugs for HIV Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drugs for HIV Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Drugs for HIV Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drugs for HIV Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drugs for HIV Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drugs for HIV Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Drugs for HIV Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drugs for HIV Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drugs for HIV Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drugs for HIV Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drugs for HIV Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Drugs for HIV Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Details
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Drugs for HIV Introduction
11.1.4 ViiV Healthcare Revenue in Drugs for HIV Business (2018-2024)
11.1.5 ViiV Healthcare Recent Developments
11.2 Gilead Sciences, Inc
11.2.1 Gilead Sciences, Inc Company Details
11.2.2 Gilead Sciences, Inc Business Overview
11.2.3 Gilead Sciences, Inc Drugs for HIV Introduction
11.2.4 Gilead Sciences, Inc Revenue in Drugs for HIV Business (2018-2024)
11.2.5 Gilead Sciences, Inc Recent Developments
11.3 Merck Sharp & Dohme Corp
11.3.1 Merck Sharp & Dohme Corp Company Details
11.3.2 Merck Sharp & Dohme Corp Business Overview
11.3.3 Merck Sharp & Dohme Corp Drugs for HIV Introduction
11.3.4 Merck Sharp & Dohme Corp Revenue in Drugs for HIV Business (2018-2024)
11.3.5 Merck Sharp & Dohme Corp Recent Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Drugs for HIV Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Drugs for HIV Business (2018-2024)
11.4.5 Bristol-Myers Squibb Company Recent Developments
11.5 Janssen Pharmaceuticals, Inc.
11.5.1 Janssen Pharmaceuticals, Inc. Company Details
11.5.2 Janssen Pharmaceuticals, Inc. Business Overview
11.5.3 Janssen Pharmaceuticals, Inc. Drugs for HIV Introduction
11.5.4 Janssen Pharmaceuticals, Inc. Revenue in Drugs for HIV Business (2018-2024)
11.5.5 Janssen Pharmaceuticals, Inc. Recent Developments
11.6 Theratechnologies Inc.
11.6.1 Theratechnologies Inc. Company Details
11.6.2 Theratechnologies Inc. Business Overview
11.6.3 Theratechnologies Inc. Drugs for HIV Introduction
11.6.4 Theratechnologies Inc. Revenue in Drugs for HIV Business (2018-2024)
11.6.5 Theratechnologies Inc. Recent Developments
11.7 Viatris Pharmaceuticals Inc.
11.7.1 Viatris Pharmaceuticals Inc. Company Details
11.7.2 Viatris Pharmaceuticals Inc. Business Overview
11.7.3 Viatris Pharmaceuticals Inc. Drugs for HIV Introduction
11.7.4 Viatris Pharmaceuticals Inc. Revenue in Drugs for HIV Business (2018-2024)
11.7.5 Viatris Pharmaceuticals Inc. Recent Developments
11.8 Genentech, Inc.
11.8.1 Genentech, Inc. Company Details
11.8.2 Genentech, Inc. Business Overview
11.8.3 Genentech, Inc. Drugs for HIV Introduction
11.8.4 Genentech, Inc. Revenue in Drugs for HIV Business (2018-2024)
11.8.5 Genentech, Inc. Recent Developments
11.9 AbbVie Inc.
11.9.1 AbbVie Inc. Company Details
11.9.2 AbbVie Inc. Business Overview
11.9.3 AbbVie Inc. Drugs for HIV Introduction
11.9.4 AbbVie Inc. Revenue in Drugs for HIV Business (2018-2024)
11.9.5 AbbVie Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs for HIV Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 3. Key Players of Integrase Inhibitors
Table 4. Key Players of Combination HIV Medicines
Table 5. Key Players of Others
Table 6. Global Drugs for HIV Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Drugs for HIV Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Drugs for HIV Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Drugs for HIV Market Share by Region (2018-2024)
Table 10. Global Drugs for HIV Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Drugs for HIV Market Share by Region (2024-2029)
Table 12. Drugs for HIV Market Trends
Table 13. Drugs for HIV Market Drivers
Table 14. Drugs for HIV Market Challenges
Table 15. Drugs for HIV Market Restraints
Table 16. Global Drugs for HIV Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Drugs for HIV Revenue Share by Players (2018-2024)
Table 18. Global Top Drugs for HIV by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for HIV as of 2022)
Table 19. Global Drugs for HIV Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Drugs for HIV Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Drugs for HIV, Headquarters and Area Served
Table 22. Global Key Players of Drugs for HIV, Product and Application
Table 23. Global Key Players of Drugs for HIV, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drugs for HIV Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Drugs for HIV Revenue Market Share by Type (2018-2024)
Table 27. Global Drugs for HIV Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Drugs for HIV Revenue Market Share by Type (2024-2029)
Table 29. Global Drugs for HIV Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Drugs for HIV Revenue Share by Application (2018-2024)
Table 31. Global Drugs for HIV Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Drugs for HIV Revenue Share by Application (2024-2029)
Table 33. North America Drugs for HIV Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Drugs for HIV Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Drugs for HIV Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Drugs for HIV Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Drugs for HIV Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Drugs for HIV Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Drugs for HIV Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Drugs for HIV Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Drugs for HIV Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Drugs for HIV Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Drugs for HIV Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Drugs for HIV Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Drugs for HIV Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Drugs for HIV Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Drugs for HIV Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Drugs for HIV Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Drugs for HIV Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Drugs for HIV Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Drugs for HIV Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Drugs for HIV Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Drugs for HIV Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Drugs for HIV Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Drugs for HIV Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Drugs for HIV Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Drugs for HIV Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drugs for HIV Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drugs for HIV Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drugs for HIV Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drugs for HIV Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drugs for HIV Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Drugs for HIV Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Drugs for HIV Market Size by Country (2024-2029) & (US$ Million)
Table 65. ViiV Healthcare Company Details
Table 66. ViiV Healthcare Business Overview
Table 67. ViiV Healthcare Drugs for HIV Product
Table 68. ViiV Healthcare Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 69. ViiV Healthcare Recent Developments
Table 70. Gilead Sciences, Inc Company Details
Table 71. Gilead Sciences, Inc Business Overview
Table 72. Gilead Sciences, Inc Drugs for HIV Product
Table 73. Gilead Sciences, Inc Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 74. Gilead Sciences, Inc Recent Developments
Table 75. Merck Sharp & Dohme Corp Company Details
Table 76. Merck Sharp & Dohme Corp Business Overview
Table 77. Merck Sharp & Dohme Corp Drugs for HIV Product
Table 78. Merck Sharp & Dohme Corp Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 79. Merck Sharp & Dohme Corp Recent Developments
Table 80. Bristol-Myers Squibb Company Company Details
Table 81. Bristol-Myers Squibb Company Business Overview
Table 82. Bristol-Myers Squibb Company Drugs for HIV Product
Table 83. Bristol-Myers Squibb Company Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 84. Bristol-Myers Squibb Company Recent Developments
Table 85. Janssen Pharmaceuticals, Inc. Company Details
Table 86. Janssen Pharmaceuticals, Inc. Business Overview
Table 87. Janssen Pharmaceuticals, Inc. Drugs for HIV Product
Table 88. Janssen Pharmaceuticals, Inc. Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 89. Janssen Pharmaceuticals, Inc. Recent Developments
Table 90. Theratechnologies Inc. Company Details
Table 91. Theratechnologies Inc. Business Overview
Table 92. Theratechnologies Inc. Drugs for HIV Product
Table 93. Theratechnologies Inc. Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 94. Theratechnologies Inc. Recent Developments
Table 95. Viatris Pharmaceuticals Inc. Company Details
Table 96. Viatris Pharmaceuticals Inc. Business Overview
Table 97. Viatris Pharmaceuticals Inc. Drugs for HIV Product
Table 98. Viatris Pharmaceuticals Inc. Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 99. Viatris Pharmaceuticals Inc. Recent Developments
Table 100. Genentech, Inc. Company Details
Table 101. Genentech, Inc. Business Overview
Table 102. Genentech, Inc. Drugs for HIV Product
Table 103. Genentech, Inc. Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 104. Genentech, Inc. Recent Developments
Table 105. AbbVie Inc. Company Details
Table 106. AbbVie Inc. Business Overview
Table 107. AbbVie Inc. Drugs for HIV Product
Table 108. AbbVie Inc. Revenue in Drugs for HIV Business (2018-2024) & (US$ Million)
Table 109. AbbVie Inc. Recent Developments
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for HIV Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drugs for HIV Market Share by Type: 2022 VS 2029
Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 4. Integrase Inhibitors Features
Figure 5. Combination HIV Medicines Features
Figure 6. Others Features
Figure 7. Global Drugs for HIV Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Drugs for HIV Market Share by Application: 2022 VS 2029
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Drugs for HIV Report Years Considered
Figure 14. Global Drugs for HIV Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Drugs for HIV Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Drugs for HIV Market Share by Region: 2022 VS 2029
Figure 17. Global Drugs for HIV Market Share by Players in 2022
Figure 18. Global Top Drugs for HIV Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for HIV as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Drugs for HIV Revenue in 2022
Figure 20. North America Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Drugs for HIV Market Share by Type (2018-2029)
Figure 22. North America Drugs for HIV Market Share by Application (2018-2029)
Figure 23. North America Drugs for HIV Market Share by Country (2018-2029)
Figure 24. United States Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Drugs for HIV Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Drugs for HIV Market Share by Type (2018-2029)
Figure 28. Europe Drugs for HIV Market Share by Application (2018-2029)
Figure 29. Europe Drugs for HIV Market Share by Country (2018-2029)
Figure 30. Germany Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Drugs for HIV Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Drugs for HIV Market Share by Type (2018-2029)
Figure 38. China Drugs for HIV Market Share by Application (2018-2029)
Figure 39. Asia Drugs for HIV Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Drugs for HIV Market Share by Type (2018-2029)
Figure 41. Asia Drugs for HIV Market Share by Application (2018-2029)
Figure 42. Asia Drugs for HIV Market Share by Region (2018-2029)
Figure 43. Japan Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Drugs for HIV Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Drugs for HIV Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Drugs for HIV Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Drugs for HIV Market Share by Country (2018-2029)
Figure 53. Brazil Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Drugs for HIV Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. ViiV Healthcare Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 60. Gilead Sciences, Inc Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 61. Merck Sharp & Dohme Corp Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 62. Bristol-Myers Squibb Company Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 63. Janssen Pharmaceuticals, Inc. Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 64. Theratechnologies Inc. Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 65. Viatris Pharmaceuticals Inc. Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 66. Genentech, Inc. Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 67. AbbVie Inc. Revenue Growth Rate in Drugs for HIV Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries